While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires ...
CAESAREA, Israel, June 23, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...
Add Yahoo as a preferred source to see more of our stories on Google. There is a less invasive, alternative treatment for some women with breast cancer who want to avoid surgery. Health reporter ...
CAESAREA, Israel, March 10, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...
CAESAREA, Israel, April 20, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys tumors by ...
Cryoablation involves applying extremely cold gas or liquid to an area of cancerous or abnormal tissue. The treatment freezes and destroys the cells. Doctors use cryoablation to treat tumors on the ...
ICESECRET completed five-year follow-up after CT-guided ProSense cryoablation, with imaging-based surveillance for local recurrence and systematic capture of procedure-related complications.
IceCure preparing for the 2026 Japanese Breast Cancer Society meeting and planned regulatory submission for breast cancer in Japan by Terumo Corporation one of the world's top 20 medical device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results